Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Loss-of-Function Mutation in PRMT9 Causes Abnormal Synapse Development by Dysregulation of RNA Alternative Splicing, Lei Shen, Xiaokuang Ma, Yuanyuan Wang, et al.
50-nm Gas-Filled Protein Nanostructures to Enable the Access of Lymphatic Cells by Ultrasound Technologies, Qionghua Shen, Zongru Li, Yixian Wang, et al.
Secondary Acquisition of the Philadelphia Chromosome in Acute Lymphoblastic Leukemia, Qiudan Shen, Elias J Jabbour, Guilin Tang, et al.
Sugar-Binding and Split Domain Combinations in Repeats-in-Toxin Adhesins From Vibrio cholerae and Aeromonas veronii Mediate Cell-Surface Recognition and Hemolytic Activities, Mustafa Sherik, Robert Eves, Shuaiqi Guo, et al.
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020, Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020, Alexander D Sherry, Andrew W Hahn, Zachary R McCaw, et al.
Improving the Clinical Meaning of Surrogate Endpoints: An Empirical Assessment of Clinical Progression in Phase III Oncology Trials, Alexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials, Alexander D Sherry, Timothy A Lin, Zachary R McCaw, et al.
Lost in the Plot: Missing Visual Elements in Kaplan-Meier Plots of Phase III Oncology Trials, Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, et al.
Postprogression Therapy and Confounding for the Estimated Treatment Effect on Overall Survival in Phase III Oncology Trials, Alexander D Sherry, Pavlos Msaouel, Timothy A Lin, et al.
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses, Alexander D Sherry, Adina H Passy, Zachary R McCaw, et al.
Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations, Ajay Sheshadri, Ravi Rajaram, Aaron Baugh, et al.
Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions, Rahul A Sheth, Eric Wehrenberg-Klee, Sapna P Patel, et al.
Escalated-Dose Radiotherapy for Unresected Locally Advanced Pancreatic Cancer: Patterns of Care and Survival in the United States, Christopher Shi, Brian De, Hop S Tran Cao, et al.
Tert Activation Targets DNA Methylation and Multiple Aging Hallmarks, Hong Seok Shim, Jonathan Iaconelli, Xiaoying Shang, et al.
Enhanced CTLA-4 Blockade Anti-tumor Immunity With APG-157 Combination in a Murine Head and Neck Cancer, Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena, et al.
Chimeric Oncolytic Adenovirus Evades Neutralizing Antibodies From Human Patients and Exhibits Enhanced Anti-Glioma Efficacy in Immunized Mice, Dong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Self-Management Intervention Improves Patient Adherence to Swallowing Exercises During Radiation for Head and Neck Cancer, Eileen H Shinn, Adam S Garden, Minxing Chen, et al.
Iterative Patient Testing of a Stimuli-Responsive Swallowing Activity Sensor to Promote Extended User Engagement During the First Year After Radiation: Multiphase Remote and In-Person Observational Cohort Study, Eileen H Shinn, Adam S Garden, Susan K Peterson, et al.
Protein-Centric Omics Analysis Reveals Circulating Complements Linked to Non-viral Liver Diseases As Potential Therapeutic Targets, Yingzhou Shi, Hang Dong, Shiwei Sun, et al.
Targeting PRMT3 Impairs Methylation and Oligomerization of HSP60 to Boost Anti-tumor Immunity by Activating cGAS/Sting Signaling, Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
survivalContour: Visualizing Predicted Survival via Colored Contour Plots, Yushu Shi, Liangliang Zhang, Kim-Anh Do, et al.
Decoding the Molecular Symphony: Interactions Between the m6A and p53 Signaling Pathways in Cancer, Rachel Shoemaker, Mo-Fan Huang, Ying-Si Wu, et al.
Gravity- vs Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study, Samira Shojaee, Jasleen Pannu, Lonny Yarmus, et al.
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML, Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.